Nebulizer Market Size, Share & Trend Analysis Report By Product (Pneumatic Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer), By Region (North America, Europe, Asia Pacific, LATAM, & MEA), And Segment Forecasts, 2018 - 2025

Industry Insights

The global nebulizer market size was valued at USD 768.5 million in 2016 and is expected to grow at a CAGR of 6.5% during the forecast period. Rising incidence of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population base are among the key factors driving market growth.

According to the Global Burden of Disease Study, an estimated 251 million people worldwide were suffering from chronic obstructive pulmonary disease (COPD) in 2016. In addition, as per the WHO (2017), there were around 3.17 million deaths due to COPD in 2015. Therefore, chronic respiratory diseases are currently posing a major challenge for health systems across the world. Initiatives such as the “Global Alliance Against Chronic Respiratory Diseases” are likely to improve diagnosis and treatmentrates of respiratory disorders.

Moreover, home healthcare devices have been gaining popularity and market presence in recent years. This is likely to be a vital impact rendering driver over the forecast period. Miniaturization of products and technological advancements are boosting the adoption of home healthcare devices. Furthermore, growing geriatric population, high incidence of target diseases, and growing need to curb healthcare expenditure are expected to be some of the high-impact rendering drivers for home healthcare devices. Home healthcare is a cost-effective alternative to expensive hospital stays. Easy availability of compact nebulizers that are ideal for home use and technological innovations to reduce the sound created by the devices and improve their functionality, are increasing their adoption in home healthcare.

The usage of nebulizers by the growing geraitric population across the globe is anticipated to increase over the forecast period. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. According to estimates published by the WHO, global elderly population is expected to increase from 841.0 million in 2014 to more than 2.0 billion in 2050. These factors are anticipated to lead to robust growth.

Rising adoption of portable nebulizers by patients is also contributing towards the market growth. Portable nebulizers are expected to witness robust growth owing to the ease and convenience of use, technological advancement in devices, and launch of several new products in recent years. There are several technological advancements incorporated into these devices to make the devices compact and minimize drug loss thereby, improving their effectiveness. For instance, the OMRON MicroAIR U22 device is portable, convenient to use, and minimizes drug loss.

Product Insights

The nebulizer market, on the basis of product is segmented into pneumatic, ultrasonic, and mesh. The pneumatic and ultrasonic nebulizer segments are further sub-segmented into standalone and portable segments. The pneumatic nebulizer segment commanded the largest market share in 2016. Factors such as high prevalence of respiratory disorders in aging population have contributed to the dominant share commanded by these devices. As per WHO, the primary cause of COPD is tobacco smoke; therefore, increase in number of smokers and rise in level of environmental pollution may lead to the growth in demand for these devices.

The mesh nebulizer segment is anticipated to witness the highest growth over the forecast period. This segment is expected to register rapid growth due to the efficacy and effectiveness of these devices, and technological advancements in these products.

Regional Insights

North America dominated the nebulizer market in 2016. COPD was estimated as the third among the leading causes of death in the U.S. in 2014 according to CDC. In 2014, as per the CDC statistics, ~15.7 million Americans were diagnosed with COPD. Moreover, a rise in the geriatric population in North America is leading to a corresponding rise in the number of respiratory disorders and surgeries in the country, which is also likely to boost the market. According to Statistics Canada, as of July 2015, ~ 16.1% of the population (~ 5,780,900 Canadians) were aged 65 years and over.

In addition, healthcare cost containment issues post the economic crisis in the U.S. have required the government to introduce new strategies to reduce patient’s stay in hospitals and readmission rates. This provided impetus to homecare services, which, in turn, created a favorable environment for growth of the nebulizer market in this region.

Asia Pacific is expected witness the highest growth over the forecast period. COPD is the seventh most common cause of death in Japan according to Japan’s Ministry of Health, Labor and Welfare. In addition, according to Institute for Health Metrics and Evaluation, in Japan, COPD cases increased by 24.2% from 2005 to 2016. Moreover, a significant percentage of population of countries such as India and China has been estimated to suffer from pulmonary diseases. These factors are bound to increase the demand for these devices in the Asia Pacific region. 

Nebulizer Market Share Insights

Few of the major players operating in this market include Omron Corporation, Koninklijke Philips N.V., PARI Pharma, Allied Healthcare Products, Inc., Becton, Dickinson and Company, Agilent Technologies, Medline Industries, Inc., Briggs Healthcare, Drive Medical, and GF Health Products, Inc.

Various strategies such as mergers & acquisitions, product approvals, and agreements are being adopted by these key market players to increase the outreach of their products and strengthen their product portfolios. For instance, in October 2015, Omron Corporation acquired Adept Technology. Through this acquisition, Omron aimed to incorporate automation in long-term care, and this is expected to positively impact the company’s business in the nebulizer market.

In addition, in April 2015, PARI Medical received European Commission authorization for its Vantobra nebulizer. The system was analyzed by the Committee for Medicinal Products for Human Use, following which it was approved.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the global nebulizer market report on the basis of product and region:

• Product Outlook Revenue (USD Million, 2014 - 2025)

  • Pneumatic

  • Ultrasonic

  • Mesh

• Product Outlook Volume (Units Sold, 2014 - 2025)

  • Pneumatic

  • Ultrasonic

  • Mesh

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • Middle East and Africa (MEA)

    • South Africa